Individual-level harm reduction intervention coverage among people in Australia who inject drugs

Price O, O'Keefe D, Colledge-Frisby S, Sutherland R, Dietze P, Bruno R, Degenhardt L, Peacock A. Individual-level harm reduction intervention coverage among people in Australia who inject drugs. Int J Drug Policy. 2025 Nov;145:105023. https://doi.org/10.1016/j.drugpo.2025.105023

Needle and syringe programs, opioid agonist treatment (OAT), and take-home naloxone (THN) are key harm reduction interventions that reduce bloodborne virus transmission and/or overdose.

This study provides updated individual-level coverage of these measures among people who inject drugs in Australia.

Read the full study in the International Journal of Drug Policy.

In this issue